RMI 10874 is a tilorone analogue with antiviral properties; it completely eliminates lung colonization of an H-2-negative (GR9.B9) MCA-induced fibrosarcoma clone in an experimental metastasis assay; it activates natural killer (NK) cells in vivo, thereby prolonging survival and inhibiting metastasis formation in mice, even after a single-dose pretreatment.